TNP1
geneOn this page
Summary
TNP1 (transition protein 1, HGNC:11951) is a protein-coding gene on chromosome 2q35, encoding Spermatid nuclear transition protein 1 (P09430). Plays a key role in the replacement of histones to protamine in the elongating spermatids of mammals.
Transition protein-1 is a spermatid-specific product of the haploid genome which replaces histone and is itself replaced in the mature sperm by the protamines (see PRM1, MIM 182880; PRM2, MIM 182890) (Luerssen et al., 1990 [PubMed 2249851]).
Source: NCBI Gene 7141 — RefSeq curated summary.
At a glance
- GWAS associations: 14
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_003284
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11951 |
| Approved symbol | TNP1 |
| Name | transition protein 1 |
| Location | 2q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000118245 |
| Ensembl biotype | protein_coding |
| OMIM | 190231 |
| Entrez | 7141 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000236979
RefSeq mRNA: 1 — MANE Select: NM_003284
NM_003284
CCDS: CCDS2406
Canonical transcript exons
ENST00000236979 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000796863 | 216859458 | 216859695 |
| ENSE00000796864 | 216859896 | 216860064 |
Expression profiles
Bgee: expression breadth ubiquitous, 150 present calls, max score 100.00.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 5.7500 / max 4864.5005, expressed in 22 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 33848 | 5.7500 | 22 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 100.00 | gold quality |
| male germ cell | CL:0000015 | 99.92 | gold quality |
| adult organism | UBERON:0007023 | 99.78 | gold quality |
| right testis | UBERON:0004534 | 99.74 | gold quality |
| left testis | UBERON:0004533 | 99.36 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.12 | gold quality |
| testis | UBERON:0000473 | 96.93 | gold quality |
| cartilage tissue | UBERON:0002418 | 85.70 | gold quality |
| cauda epididymis | UBERON:0004360 | 79.59 | gold quality |
| endometrium epithelium | UBERON:0004811 | 78.93 | gold quality |
| cerebellar vermis | UBERON:0004720 | 76.29 | silver quality |
| caput epididymis | UBERON:0004358 | 76.19 | gold quality |
| paraflocculus | UBERON:0005351 | 74.60 | silver quality |
| corpus epididymis | UBERON:0004359 | 73.49 | silver quality |
| right coronary artery | UBERON:0001625 | 73.10 | gold quality |
| frontal pole | UBERON:0002795 | 72.99 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.40 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 72.15 | gold quality |
| olfactory bulb | UBERON:0002264 | 71.46 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 68.86 | gold quality |
| type B pancreatic cell | CL:0000169 | 68.84 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 68.55 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 68.13 | gold quality |
| right uterine tube | UBERON:0001302 | 67.90 | gold quality |
| thyroid gland | UBERON:0002046 | 66.99 | gold quality |
| ectocervix | UBERON:0012249 | 66.91 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 66.29 | gold quality |
| diaphragm | UBERON:0001103 | 66.12 | gold quality |
| endocervix | UBERON:0000458 | 64.79 | gold quality |
| vastus lateralis | UBERON:0001379 | 64.79 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 31677.66 |
| E-GEOD-124263 | yes | 14692.27 |
| E-HCAD-38 | yes | 9078.94 |
| E-ANND-3 | no | 1.32 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MBD2, RBPJ
miRNA regulators (miRDB)
10 targeting TNP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-548AU-3P | 99.70 | 68.22 | 1373 |
| HSA-MIR-3147 | 99.52 | 66.34 | 388 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
| HSA-MIR-3127-3P | 98.94 | 67.34 | 1055 |
| HSA-MIR-6756-3P | 98.94 | 66.79 | 1104 |
| HSA-MIR-4799-3P | 97.78 | 65.97 | 893 |
| HSA-MIR-4720-5P | 97.46 | 65.67 | 893 |
| HSA-MIR-5588-5P | 97.46 | 65.70 | 913 |
Literature-anchored findings (GeneRIF, showing 7)
- a deletion of 15 nucleotides encompassing the recognition site for the cAMP response element transcription factor was found in the 5’-promoter region of the TNP1 gene in infertile men; this deletion reduces TNP1 expression and may cause infertility (PMID:16291974)
- We found significantly lower levels of HILS1, TNP1, and TNP2 transcripts in spermatozoa from asthenozoospermic men compared to normozoospermic men. (PMID:17852044)
- The TNP1 contributes not only to successful fertilization, but may has an important impact in development of preimplantation embryos. (PMID:18292840)
- The presence of transition proteins (TP1 and/or TP2) in spermatids in semen indicates inhibition in the differentiation pathway from round spermatids to spermatozoa in infertile men. (PMID:18727729)
- frequency of the haplotype GCG (H3) was increased in azoospermic men compared with fertile men. expression analysis of the TNP1 gene in obstructive azoospermic men showed that haplotypes of the TNP1 gene do not affect its expression level. (PMID:20522125)
- Among Systemic lupus erythematosus patients, 63.6% and 45.5% of those with lupus nephritis were positive for anti-RRP8 and anti-TNP1 antibodies, compared with 12.5% and 9.4% of Systemic lupus erythematosus patients without nephritis, respectively. (PMID:26098692)
- Tobacco smoking and its impact on the expression level of sperm nuclear protein genes: H2BFWT, TNP1, TNP2, PRM1 and PRM2. (PMID:33440036)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tnp1 | ENSMUSG00000026182 |
| rattus_norvegicus | Tnp1 | ENSRNOG00000017611 |
Protein
Protein identifiers
Spermatid nuclear transition protein 1 — P09430 (reviewed: P09430)
All UniProt accessions (2): P09430, Q4ZG82
UniProt curated annotations — full annotation on UniProt →
Function. Plays a key role in the replacement of histones to protamine in the elongating spermatids of mammals. In condensing spermatids, loaded onto the nucleosomes, where it promotes the recruitment and processing of protamines, which are responsible for histone eviction.
Subcellular location. Nucleus. Chromosome.
Tissue specificity. Expressed by spermatids (at protein level).
Similarity. Belongs to the nuclear transition protein 1 family.
RefSeq proteins (1): NP_003275* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001319 | Nuclear_transition_prot1 | Family |
| IPR020062 | Nuclear_transition_prot1_CS | Conserved_site |
Pfam: PF02079
UniProt features (5 total): modified residue 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P09430-F1 | 61.97 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 9, 40
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 125 (showing top):
MORF_RAGE, GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION, GOBP_SINGLE_FERTILIZATION, CAR_TNFRSF25, WWTAAGGC_UNKNOWN, GOBP_MALE_GAMETE_GENERATION, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_PROTEIN_MATURATION, GOBP_NUCLEUS_ORGANIZATION, GOBP_CILIUM_MOVEMENT, CAR_MYST2, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_DNA_DAMAGE_RESPONSE, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM
GO Biological Process (15): single strand break repair (GO:0000012), nucleosome disassembly (GO:0006337), chromatin remodeling (GO:0006338), spermatid development (GO:0007286), spermatid nucleus differentiation (GO:0007289), spermatid nucleus elongation (GO:0007290), positive regulation of protein processing (GO:0010954), sexual reproduction (GO:0019953), flagellated sperm motility (GO:0030317), heterochromatin formation (GO:0031507), sperm DNA decondensation (GO:0035041), sperm DNA condensation (GO:0035092), negative regulation of DNA-templated transcription (GO:0045892), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (2): DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (4): nucleosome (GO:0000786), male germ cell nucleus (GO:0001673), nucleus (GO:0005634), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin organization | 3 |
| nucleus organization | 2 |
| spermatid nucleus differentiation | 2 |
| DNA repair | 1 |
| protein-DNA complex disassembly | 1 |
| nucleosome organization | 1 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| spermatid development | 1 |
| protein processing | 1 |
| positive regulation of proteolysis | 1 |
| regulation of protein processing | 1 |
| positive regulation of protein maturation | 1 |
| reproductive process | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| cellular component assembly | 1 |
| heterochromatin boundary formation | 1 |
| negative regulation of gene expression, epigenetic | 1 |
| heterochromatin organization | 1 |
| male pronucleus assembly | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromatin | 1 |
| protein-DNA complex | 1 |
| germ cell nucleus | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1140 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TNP1 | TNP2 | Q05952 | 973 |
| TNP1 | PRM1 | P04553 | 959 |
| TNP1 | PRM2 | P04554 | 958 |
| TNP1 | KDM3A | Q9Y4C1 | 855 |
| TNP1 | NUPR1 | O60356 | 838 |
| TNP1 | TSSK6 | Q9BXA6 | 812 |
| TNP1 | VIL1 | P09327 | 772 |
| TNP1 | SPEM1 | Q8N4L4 | 743 |
| TNP1 | ACR | P10323 | 712 |
| TNP1 | PRM3 | Q9NNZ6 | 681 |
| TNP1 | SYCP3 | Q8IZU3 | 666 |
| TNP1 | KPNA3 | O00505 | 645 |
| TNP1 | ODF1 | Q14990 | 617 |
| TNP1 | DMRT1 | Q9Y5R6 | 581 |
| TNP1 | STRA8 | Q7Z7C7 | 576 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TNP1 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| SDCBP2 | TNP1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| TNP1 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TNP1 | DVL3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (13): SDCBP2 (Two-hybrid), DVL3 (Two-hybrid), RPL6 (Cross-Linking-MS (XL-MS)), TNP1 (Biochemical Activity), TNP1 (Biochemical Activity), TNP1 (Biochemical Activity), TNP1 (Biochemical Activity), TNP1 (Affinity Capture-Western), TNP1 (Reconstituted Complex), TNP1 (Two-hybrid), TNP1 (Two-hybrid), TNP1 (Two-hybrid), PPARG (Reconstituted Complex)
ESM2 similar proteins: A1RRN8, A2STI9, A4G029, A4WLS6, A6UVQ6, A6VIE9, A9A8D5, B1YAF1, B6YWY4, B8GEU4, O16130, O27650, O28212, O97965, P02317, P04650, P05733, P09430, P10856, P11340, P13275, P17305, P17306, P22613, P49166, P52814, P59289, P59473, P61927, P61928, P79244, P83266, P83267, P87558, Q09821, Q43292, Q54MG6, Q6L2L2, Q6M0V9, Q8JN70
Diamond homologs: P02317, P09430, P10856, P17305, P17306, P22613
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
155 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:216859967:C:CA | donor_gain | 1.0000 |
| 2:216859915:A:AC | donor_gain | 0.9900 |
| 2:216859916:C:CC | donor_gain | 0.9900 |
| 2:216859933:A:AC | donor_gain | 0.9900 |
| 2:216859934:C:CC | donor_gain | 0.9900 |
| 2:216859950:TGC:T | donor_gain | 0.9800 |
| 2:216859952:C:CT | donor_gain | 0.9800 |
| 2:216859953:C:CT | donor_gain | 0.9800 |
| 2:216859696:C:CC | acceptor_gain | 0.9600 |
| 2:216859692:TTGG:T | acceptor_gain | 0.9500 |
| 2:216859714:T:TC | acceptor_gain | 0.9500 |
| 2:216859934:CGGTA:C | donor_gain | 0.9500 |
| 2:216859714:T:C | acceptor_gain | 0.9400 |
| 2:216859949:CTG:C | donor_gain | 0.9400 |
| 2:216859693:TGG:T | acceptor_gain | 0.9300 |
| 2:216859694:GG:G | acceptor_gain | 0.9300 |
| 2:216859696:C:T | acceptor_loss | 0.9300 |
| 2:216859697:T:A | acceptor_loss | 0.9300 |
| 2:216859934:CGGT:C | donor_gain | 0.9300 |
| 2:216859888:TCAC:T | donor_loss | 0.9200 |
| 2:216859890:ACT:A | donor_loss | 0.9200 |
| 2:216859891:CTCA:C | donor_loss | 0.9200 |
| 2:216859892:T:TA | donor_loss | 0.9200 |
| 2:216859698:G:C | acceptor_gain | 0.9100 |
| 2:216859917:T:C | donor_gain | 0.9100 |
| 2:216859710:A:T | acceptor_gain | 0.8800 |
| 2:216859951:G:GC | donor_gain | 0.8800 |
| 2:216859691:ATTGG:A | acceptor_gain | 0.8600 |
| 2:216859911:T:A | donor_gain | 0.8600 |
| 2:216859698:G:GC | acceptor_gain | 0.8500 |
AlphaMissense
361 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:216859969:C:A | K22N | 0.961 |
| 2:216859969:C:G | K22N | 0.961 |
| 2:216859968:C:G | G23R | 0.956 |
| 2:216859968:C:T | G23R | 0.956 |
| 2:216859967:C:T | G23E | 0.926 |
| 2:216859960:C:A | K25N | 0.915 |
| 2:216859960:C:G | K25N | 0.915 |
| 2:216859971:T:C | K22E | 0.915 |
| 2:216859964:A:T | V24D | 0.909 |
| 2:216860023:G:C | S4R | 0.902 |
| 2:216860023:G:T | S4R | 0.902 |
| 2:216860025:T:G | S4R | 0.902 |
| 2:216859970:T:A | K22M | 0.898 |
| 2:216859957:T:A | R26S | 0.895 |
| 2:216859957:T:G | R26S | 0.895 |
| 2:216859970:T:G | K22T | 0.880 |
| 2:216860022:G:T | R5S | 0.877 |
| 2:216860011:C:A | K8N | 0.857 |
| 2:216860011:C:G | K8N | 0.857 |
| 2:216859974:G:C | H21D | 0.851 |
| 2:216859962:T:C | K25E | 0.849 |
| 2:216859945:T:A | K30N | 0.847 |
| 2:216859945:T:G | K30N | 0.847 |
| 2:216860013:T:C | K8E | 0.843 |
| 2:216860008:A:C | S9R | 0.830 |
| 2:216860008:A:T | S9R | 0.830 |
| 2:216860010:T:G | S9R | 0.830 |
| 2:216860021:C:G | R5P | 0.826 |
| 2:216860030:G:C | S2W | 0.817 |
| 2:216859946:T:A | K30I | 0.813 |
dbSNP variants (sampled 300 via entrez): RS1000538377 (2:216861338 A>G), RS1000833661 (2:216861014 C>T), RS1000926993 (2:216861070 G>C), RS1001809463 (2:216860088 G>C), RS1003315001 (2:216859384 T>C), RS1004905445 (2:216859076 G>A,C), RS1007109873 (2:216861819 T>C), RS1008043943 (2:216860905 A>G), RS1008213844 (2:216860336 G>C), RS1009210192 (2:216861757 G>A), RS1009471859 (2:216861410 T>C), RS1010537148 (2:216860950 AG>A), RS1013014909 (2:216861290 T>C), RS1014052375 (2:216861417 AT>A), RS1014607101 (2:216860419 A>C)
Disease associations
OMIM: gene MIM:190231 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
14 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001221_3 | Permanent tooth development | 2.000000e-14 |
| GCST002647_80 | Height | 4.000000e-09 |
| GCST003094_2 | Mitral valve prolapse | 3.000000e-11 |
| GCST003988_20 | Hypothyroidism | 6.000000e-09 |
| GCST005351_1 | Carboplatin disposition in epthelial ovarian cancer | 5.000000e-06 |
| GCST005984_27 | Glomerular filtration rate | 1.000000e-09 |
| GCST005985_63 | Creatinine levels | 4.000000e-09 |
| GCST007096_6 | Pulse pressure | 5.000000e-08 |
| GCST008058_174 | Estimated glomerular filtration rate | 2.000000e-34 |
| GCST008059_138 | Estimated glomerular filtration rate | 3.000000e-29 |
| GCST008060_20 | Estimated glomerular filtration rate | 4.000000e-06 |
| GCST008064_12 | Chronic kidney disease | 2.000000e-06 |
| GCST008839_204 | Height | 5.000000e-07 |
| GCST010653_62 | Thyroid stimulating hormone levels | 3.000000e-78 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| uranyl acetate | affects expression | 1 |
| hydroxyhydroquinone | decreases expression | 1 |
| 3,4,3’,4’-tetrachlorobiphenyl | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Uranium | affects expression | 1 |
| Valproic Acid | affects expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chronic kidney disease, hypothyroidism